11/25
07:31 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Werewolf Therapeutics (NASDAQ:HOWL) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/18
01:13 pm
howl
Werewolf Therapeutics (NASDAQ:HOWL) had its price target lowered by analysts at Bank of America Corporation from $8.00 to $7.00. They now have a "buy" rating on the stock.
Medium
Report
Werewolf Therapeutics (NASDAQ:HOWL) had its price target lowered by analysts at Bank of America Corporation from $8.00 to $7.00. They now have a "buy" rating on the stock.
11/12
08:05 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Werewolf Therapeutics (NASDAQ:HOWL) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
11/7
09:00 am
howl
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Low
Report
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
11/4
07:00 am
howl
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Neutral
Report
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
10/18
07:31 am
howl
Werewolf Therapeutics (NASDAQ:HOWL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Neutral
Report
Werewolf Therapeutics (NASDAQ:HOWL) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
10/8
08:36 am
howl
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer [Yahoo! Finance]
Medium
Report
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer [Yahoo! Finance]
10/8
08:00 am
howl
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer
Low
Report
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer
10/3
09:45 am
howl
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting [Yahoo! Finance]
Medium
Report
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting [Yahoo! Finance]
10/3
09:00 am
howl
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Medium
Report
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
9/8
06:23 pm
howl
Werewolf Therapeutics, Inc. (HOWL) Just Flashed Golden Cross Signal: Do You Buy? [Yahoo! Finance]
Neutral
Report
Werewolf Therapeutics, Inc. (HOWL) Just Flashed Golden Cross Signal: Do You Buy? [Yahoo! Finance]